This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Summary
Valerian is a plant used in some non-prescription natural health products.
- Generic Name
- Valerian
- DrugBank Accession Number
- DB13196
- Background
Valerian is extracted from a herb that is a perennial flowering plant. Valerian root is reported to have sedative and anxiolytic effects however its mechanism of action is not completely understood. Valerian has been used in the treatment of conditions including sleep disorders, anxiety, attention deficit-hyperactivity disorder (ADHD) and joint pain. Valproic acid is a derivative of valeric acid, which is obtained from the plant root. Valerian is a food ingredient permitted for direct addition to food for human consumption as a natural flavoring substance.
- Type
- Biotech
- Groups
- Approved, Experimental, Investigational
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Valerianae radix
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Artryl Cap 200 mg Capsule 200 mg Oral Les Laboratoires Vachon Inc. 1994-12-31 2007-07-12 Canada 
Effidose Valeriane Liq 1916mg/10ml Amp Liquid 1.916 g / amp Oral Laboratoires Charton Laboratories 1995-12-31 1999-01-16 Canada Ethical Herbals Sleep Aid Tablet 170 mg Oral Ashbury Research Corporation Not applicable Not applicable Canada Facilite Le Sommeil - Cap 270mg Capsule 270 mg Oral Laboratoire Lalco Inc. 1997-01-20 2002-09-05 Canada Hermes No6 Tea Liquid 120 mg / 5 mL Oral Hermes Arzneimittel Gmbh 1958-12-31 1999-07-08 Canada Kalm Caps Capsule 175 mg Oral Rheingold Food International Ltd. 1985-12-31 2001-07-06 Canada Nervatex Tab 500mg Tablet 500 mg / tab Oral Carmaran LtÉe 1980-12-31 1996-09-09 Canada Nervatex Tablets 500mg Tablet 500 mg / tab Oral Pharmetics (2011) Inc. 1995-12-31 2000-08-21 Canada Phytocalm Capsule 150 mg / cap Oral SantÉ Naturelle (Ag) LtÉe 1998-12-13 2004-08-05 Canada Salus Valerian Tct Tincture 166.7 mg / mL Oral Salus Haus 1979-12-31 2003-07-24 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Bio-strath No. 8 Gouttes Valerian (0.225 mL / mL) + Passiflora incarnata flower (0.225 mL / mL) + Peppermint (0.05 mL / mL) Solution / drops Oral Bio Strath Ag 1989-12-31 2008-07-24 Canada Dormiphen Au Naturel Valerian (400 mg) + Passiflora incarnata flower (400 mg) Capsule Oral Laboratoire Lalco Inc. Not applicable Not applicable Canada Herbal Nerve - Tablet Valerian (300 mg) + Scutellaria lateriflora (350 mg) Tablet Oral Swiss Herbal Remedies Ltd. 1995-12-31 2009-08-04 Canada Herbal Nerve Tab Valerian (50 mg) + Hops (50 mg) + Scutellaria lateriflora (100 mg) Tablet Oral Vita Health Products Inc 1977-12-31 2005-07-20 Canada Herbal Relax Valerian (120 mg) + Chamomile (460 mg) Capsule Oral Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. 1998-11-05 2002-07-29 Canada Herbal Relaxant - Tablet Valerian (500 mg) + Chamomile (200 mg) Tablet Oral Quest Vitamins A Div Of Purity Life Health Products 1995-12-31 2001-07-06 Canada Herbal Sleep Valerian (600 mg) + Chamomile (100 mg) + Hops (165 mg) + Passiflora incarnata flower (175 mg) Capsule Oral Puresource Inc. Not applicable Not applicable Canada Herbal Sleep Aid Valerian (400 mg) + Hops (100 mg) + Passiflora incarnata flower (100 mg) Capsule Oral Wampole Brands, A Division Of Pangeo Pharma (Canada) Inc. 1998-11-05 2002-07-29 Canada Herbal Slumber Cap Valerian (177 mg) + Hops (67 mg) + Peppermint (153 mg) + Scutellaria lateriflora (153 mg) Capsule Oral Pep Products Inc. 1992-12-31 1999-10-29 Canada Hops-valerian Combination Cap Valerian (133 mg) + Hops (134 mg) + Scutellaria lateriflora (133 mg) Capsule Oral Nature's Herbs Inc. 1995-12-31 1997-05-30 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Medi-doze Rx Sleep Aid Valerian (50 mg/1) + Melatonin (6 mg/1) + gamma-Aminobutyric acid (30 mg/1) Tablet Oral Two Hip Consulting, Llc 2013-02-20 2016-04-11 US 
Categories
- ATC Codes
- N05CM09 — Valerianae radix
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- JWF5YAW3QW
- CAS number
- 8057-49-6
References
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 3 Unknown Status Treatment Anxiety Disorders 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Oral Capsule Oral 200 mg Solution / drops Oral Liquid Oral 1.916 g / amp Tablet Oral 170 mg Capsule Oral 270 mg Injection, solution Intramuscular Syrup Oral Liquid Oral 120 mg / 5 mL Capsule Oral 175 mg Tablet Oral Tablet Oral 500 mg / tab Capsule Oral Capsule Oral 170 mg / cap Tablet Oral 600 mg / tab Capsule Oral 150 mg / cap Tablet Oral 600 mg Tablet Oral 140 mg / tab Tincture Oral 166.7 mg / mL Powder Oral Capsule Oral 100 mg / tab Tablet Oral 100 mg Capsule Oral 560 mg For solution Oral Tincture Oral 200 mg / mL Capsule Oral 300 mg Capsule Oral 410 mg / cap Capsule Oral 500 mg / cap Capsule Oral 500 mg Capsule Oral 450 mg / cap Tablet Oral 800 mg / tab Capsule Oral 400 mg Capsule Oral 470 mg / cap Capsule Oral 470 mg Tincture Oral 435 mg / mL Liquid Oral .125 g / mL Tablet, coated Tablet, coated Oral Tablet Oral 140 mg Capsule Oral 270 mg / cap Liquid Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at June 23, 2017 20:37 / Updated at October 26, 2021 21:40